Patents by Inventor Bruce Roe

Bruce Roe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10356496
    Abstract: The technology relates to a converged passive optical local access network. The converged passive optical local access network may include a network switch, one or more passive optical splitters, one or more optical network terminals, one or more user devices, and a converged optical line terminal. The converged optical line terminal is integrated into a server and comprised of one or more fiber-optic network interface cards. The converged optical line terminal is configured to manage the transmission of data between the converged passive optical local access network and an external network.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: July 16, 2019
    Assignee: Accelink Technologies Co., Ltd.
    Inventors: Bruce Roe, Weyl Wang
  • Publication number: 20170214984
    Abstract: The technology relates to a converged passive optical local access network. The converged passive optical local access network may include a network switch, one or more passive optical splitters, one or more optical network terminals, one or more user devices, and a converged optical line terminal. The converged optical line terminal is integrated into a server and comprised of one or more fiber-optic network interface cards. The converged optical line terminal is configured to manage the transmission of data between the converged passive optical local access network and an external network.
    Type: Application
    Filed: January 27, 2017
    Publication date: July 27, 2017
    Inventors: Bruce Roe, Weyl Wang
  • Patent number: 5935783
    Abstract: Transcription units encoded in the minimal DGS/VCFS critical region, primer pairs effective for amplifying said transcripts in a genomic DNA sample for the preparation of probes for detecting genetic deletions/mutations in the minimal DGS/VCFS critical region, and kits containing the probes are disclosed. One or more of said transcription units is implicated for the abnormalities associated with DGS/VCFS.
    Type: Grant
    Filed: December 27, 1996
    Date of Patent: August 10, 1999
    Assignees: Children's Hospital of Philadelphia, University of Oklahoma
    Inventors: Weilong Gong, Beverly S. Emanuel, Marcia L. Budarf, Bruce Roe